U.S. Sustainable Energy Corporation and Nanobac Pharmaceuticals, Inc.
Investigate Nanobacteria Link to Energy Production
TAMPA, FL -- (MARKET WIRE) -- 04/18/2006 -- U.S. Sustainable Energy
Corporation ("U.S. Sustainable" or "the Company") announced today that
it is investigating and conducting joint research with Nanobac
Pharmaceuticals, Inc. ("Nanobac") (OTC BB: NNBP) on a possible
connection between nanobacteria, or calcifying nano-particles, and its
proprietary process for the production of biofuels from various biomass
feedstocks using the Company's technologies.
The Company's technologies will include the rights to the certain
patents and intellectual property rights currently contained in
EarthFirst Technologies, Inc. (OTC BB: EFTI). Under EarthFirst's
previously announced planned merger with Cast-Crete Corporation,
EarthFirst/Cast-Crete will become the co-proponent of the Plan of
Reorganization of CyberCare, Inc. ("CyberCare") (OTC: CYBR). After the
merger with Cast-Crete and CyberCare's emergence from reorganization,
EarthFirst/Cast-Crete intend to combine the existing energy
technologies with CyberCare's technology assets. The surviving entity
will be known as U.S. Sustainable Energy Corporation.
Nanobac has previously announced published research that demonstrated
the role nanobacteria play in the production of electricity. A fuel
cell was used to enrich a microbial consortium generating electricity.
Nanobacteria-like particles were present on the biofilm surface.
John Stanton, Chairman of both Nanobac and U.S. Sustainable, stated
that Nanobac's continuing research with the National Aeronantics and
Space Administration ("NASA") suggests potential energy, as well as
healthcare, implications of nanobacteria. Our goal is to discover, or
invent, and then commercialize technologies that enhance our way of
life through sustainable energy development that "does no harm" to our
health, or environment.
It has been substantiated that calcific diseases propagate in
microgravity because nanobacteria growth in that environment is
accelerated. We are specifically investigating whether or not the
vacuum created in the biofuel production process might accelerate
nanobacteria growth, thus enhancing biofuel productivity.
Investors are cautioned that certain statements contained in this
document as well as some statements in periodic press release and some
oral statement of Nanobac Pharmaceuticals, Inc. officials are
"Forward-Looking Statements" within the meaning of the Private
Securities Litigation Reform Act of 1995 (the "Act"). Forward-Looking
statements include statements which are predictive in nature, which
depend upon or refer to future events or conditions, which include
words such as "believes," "anticipates," "intends," "plans," "expects,"
and similar expressions. In addition, any statements concerning future
financial performance (including future revenues, earnings or growth
rates), ongoing business strategies or prospects, and possible future
Nanobac actions, which may be provided by management, are also
forward-looking statements as defined by the Act. Forward-Looking
statements involve known and unknown risks, uncertainties, and other
factors which may cause the actual results, performance or achievements
of the Company to materially differ from any future results,
performance or achievements expressed or implied by such
forward-looking statements and to vary significantly from reporting
period to reporting period. Although management believes that the
assumptions will, in fact, prove to be correct or that actual future
results will not be different from the expectations expressed in this
report. These statements are not guarantees of future performance and
Nanobac has no specific intention to update these statements.
--------------------------------------------------------------------------------
U.S. SUSTAINABLE ENERGY CORPORATION, TAMPA
John Stanton
813-621-4641
SOURCE: U.S. Sustainable Energy Corp
|
